from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3467/-

LFCtreatmentdescriptionclass of inhibitor

-0.467

Amikacinug/mL Amikacintranslation

-0.551

Cap5-10ug/mL Capreomycintranslation

-0.890

Rox10-50 ug/mL Roxithromycintranslation

-0.376

SM2-5 ug/mL Streptomycintranslation

-2.189

Tet5-10 ug/mL Tetracyclinetranslation

0.166

Rif0.2-5ug/mL Rifampicintranscription

-0.478

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.995

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.493

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.476

CPZ10-50 ug/mL Chlorpromazinerespiration

0.857

Clofazimine10-13 ug/mL Clofaziminerespiration

0.126

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.753

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.572

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.590

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.153

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.190

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.819

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.494

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

2.291

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.452

KCN5-20 ug/mL Potassium cyaniderespiration

-0.043

NaN30.2-2 mM Sodium aziderespiration

-0.296

Nigericin50 uM Nigericinrespiration

0.044

TRC10-150 ug/mL Triclosanrespiration

1.505

TRZ10-25 ug/mL Thioridazinerespiration

0.406

Valinomycin0.5-10 uM Valinomycinrespiration

-0.504

ZnSO42 mM ZnSO4respiration

1.551

menadione6-10 ug/mL Menadionerespiration

-0.469

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.896

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.331

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.236

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.622

NRP_1Non-replicating persistence stage 1dosRassociated

-0.010

Amp0.2mg/mL AmpicillincellWall

-0.720

Cephalexin20-100 ug/mL CephalexincellWall

-0.842

Cerulenin0.32-5 ug/mL CerulenincellWall

0.181

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.175

EMB10-20 ug/mL EthambutolcellWall

-0.542

Eta12-40 ug/mL EthionamidecellWall

-0.670

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.016

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.077

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.306

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.150

BZA0.12 mg/mL BenzamidearomaticAmides

0.337

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.254

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.664

H2O24 mM hydrogen peroxideDNAdamaging

1.613

Levo10 ug/mL LevofloxacinDNAdamaging

0.048

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

2.151

Novobiocin10 ug/mL NovobiocinDNAdamaging

2.096

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.043

UVUV-irradiationDNAdamaging

0.595

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.687

Antimycin12.5-50 ug/mL Antimycin A?

-0.181

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-1.062

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.649

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.885

PA8240.2-2 ug/mL PA-824?

-1.105

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-1.065

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.280

Verapamil50 uM Verapamil?

0.175

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.020

methoxatin10-20 ug/mL Methoxatin?